Share of Cost, Advanced Treatment Technologies For Prostate Cancer Among Men With Low Risk Disease

Sunday, Feb. 9th 2014 8:00 AM

Use of advanced treatment technologies for prostate cancer, such as intensitymodulated radiotherapy and robotic prostatectomy, has increased among men with lowrisk disease, high risk of noncancer mortality, or both, a population of patients who are unlikely to benefit from these treatments, according to a study in the June 26 issue of JAMA. “Prostate cancer is a common and expensive disease in the United States. In part because of the untoward morbidity of traditional radiation and surgical therapies, advances in the treatment of localized disease have evolved over the last decade.

Posted on Sunday, Feb. 9th 2014 8:00 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.